TY - JOUR AU - Maughan, T S TI - Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial JO - Lancet VL - 377 PY - 2011 DO - 10.1016/S0140-6736(11)60613-2 L3 - PubMed-ID: 21641636 SP - 2103 EP - 2114 N1 - et al. ER -